Observe_Medical_ASA_Company_Presentation_trading_update_25_March_2026
Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2026-03-25 11:01:56
Oslo, 25 March 2026.
With reference to today's webcast, please find enclosed the presentation.
Key topics:
· 80% growth in quarterly sales LTM
· Commercial launch of UnoMeterT Safeti Max
· Extended product offering to our distributors, capitalizing on the UnoMeter
brand position
· Sales in 46 countries
· Current addressable market value grown from NOK ~670m to ~2.6bn
A recording of the presentation is also available
at:https://qcnl.tv/p/OLaQ0Xa8KdjTtD9W3cv0PQ
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.